# HealWELL AI (AIDX.TO) fundamentals

Data as of 2026-09-08. TSX, Canada. Sector: Healthcare / Health Care Providers & Services. Price C$0.81, market value C$271 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). HealWELL AI reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 2.1×**. Each dollar of revenue is priced at 2.1×.
- **Price / book: 1.9×**. The shares trade at 1.9× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 32.6×**. Enterprise value is 32.6× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: -3.0%** (5-yr avg -18.1%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Gross margin: 44.8%**. HealWELL AI keeps 44.8% of revenue after the direct cost of what it sells.
- **Operating margin: -18.6%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -45.2%**. The company reported a net loss over the last twelve months.
- **Return on equity: -37.9%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -12.5%**. Return on all capital, debt included, is -12.5%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -10.4%**. Each dollar of assets produces -10.4% of profit.

## Growth
- **Revenue growth (1 yr): 166.4%** (3-yr 115.1%/yr, 5-yr 21.9%/yr). Revenue grew 166.4% over the last year, against 21.9% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 0.0%**. Earnings per share rose 0.0%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 0.69**. Debt is 0.69 times equity, moderate leverage.
- **Net debt / EBITDA: 6.5×**. It would take 6.5 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Interest coverage: -1.8×**. Operating profit covers interest only -1.8×: fragile.
- **Current ratio: 0.91** (quick 0.91). Current liabilities exceed current assets, so the company depends on ongoing cash generation or refinancing to pay the next year's bills.
- **Altman Z-score: 1.61**. A Z-score of 1.61 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. HealWELL AI does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (11 analysts). 11 analysts cover HealWELL AI; the consensus is strong_buy, with an average price target of C$1.84 (+127% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -36.7%** (YTD -3.6%, 3-mo -6.9%). The shares are down 36.7% over twelve months including dividends.
- **From 52-week high: -49.7%** (39.7% above the low). Trading 50% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 59**. An RSI of 59 is neutral.
- **Beta (1 yr): 1.17** (volatility 59%). Beta of 1.17 against the S&P/TSX Composite: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=AIDX.TO · Page: https://foliofundamentals.com/stocks/aidx.to

Not investment advice.